MBLY vs TECH · rev $1.65B vs P/E 65, rev $1.22B
Mobileye Global Inc. Class A Common Stock (MBLY) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Mobileye Global Inc. Class A Common Stock (MBLY) is a auto parts company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported MBLY revenue for 2024-12-28 was $1.65B. Net income was -$3.09B. Revenue was down 20.4% from 2023-12-30 to 2024-12-28. MBLY currently screens at market cap $12.99B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
MBLY currently screens at market cap $12.99B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the MBLY and TECH stock pages for the full models.
Not investment advice.